Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Recombinant Human Growth Hormone (r-hGH)
100%
Severely Burned
100%
Growth Hormone Treatment
100%
Randomized Controlled Trial
100%
Long-term Growth
100%
Burned children
100%
Postburn
42%
Scar
42%
Massive Burns
42%
Pediatric Patients
42%
Long-term Treatment
28%
Placebo
28%
Cardiac Output
28%
Lean Body Mass
28%
Body Composition
28%
Bone Metabolism
28%
Hypermetabolism
28%
Resting Energy Expenditure
28%
Growth Hormone
14%
Hypermetabolic
14%
Growth Factors
14%
Hormone Administration
14%
Total Body Surface Area
14%
Long-term Administration
14%
Cardiac Performance
14%
Statistical Analysis
14%
Insulin-like
14%
Prospective Clinical Trial
14%
Over 40
14%
Prospective Randomized Trial
14%
Catabolic Response
14%
Body Fat Content
14%
Bone Mineral Content
14%
Change in Weight
14%
Bonferroni Correction
14%
Body Fat Percentage
14%
RhGH
14%
Enhanced Recovery
14%
Tukey
14%
Disintegration
14%
Single Center
14%
Insulin-like Growth Factor Binding protein-3 (IGFBP-3)
14%
Enhanced Growth
14%
Subset Analysis
14%
Osteocalcin
14%
Patient Discharge
14%
Body Mass Gain
14%
Controlled Clinical Trial
14%
Immunology and Microbiology
Heart Output
100%
Lean Body Weight
100%
Body Composition
100%
Resting Energy Expenditure
100%
Scar Formation
100%
Bone Remodeling
100%
Surface Area
50%
Somatomedin C
50%
Body Surface
50%
Body Fat
50%
Heart Work
50%
Bone Mineral
50%
Growth Hormone Blood Level
50%
Medicine and Dentistry
Growth Hormone
100%
Human Growth Hormone
100%
Randomized Controlled Trial
100%
Pediatrics Patient
42%
Placebo
28%
Heart Output
28%
Lean Body Weight
28%
Scar Formation
28%
Hypermetabolism
28%
Resting Energy Expenditure
28%
Bone Remodeling
28%
Clinical Trial
14%
Thermal Burn
14%
Heart Work
14%
Body Surface
14%
Parathyroid Hormone
14%
Somatomedin C
14%
Body Weight
14%
Body Fat
14%
Fat Content
14%
Student T Test
14%
Analysis of Variance
14%
Controlled Clinical Trial
14%
Bone Mineral
14%
Osteocalcin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Growth Hormone
100%
Human Growth Hormone
100%
Randomized Controlled Trial
100%
Placebo
28%
Hypermetabolism
28%
Scar Formation
28%
Clinical Trial
14%
Parathyroid Hormone
14%
Somatomedin C
14%
Controlled Clinical Trial
14%
Osteocalcin
14%